2/5
10:58 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
1/28
09:00 am
mdln
Medline to report fourth quarter and full year 2025 results on February 25, 2026
Medium
Report
Medline to report fourth quarter and full year 2025 results on February 25, 2026
1/23
04:03 pm
mdln
Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]
Low
Report
Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]
1/21
10:11 am
mdln
Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..
Low
Report
Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..
1/21
09:04 am
mdln
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/15
07:47 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Rothschild Redb to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Rothschild Redb to a "hold" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Baird R W to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at BMO Capital Markets to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at BMO Capital Markets to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
1/12
12:00 pm
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $50.00 price target on the stock.
1/12
11:00 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $48.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $48.00 price target on the stock.
1/12
10:04 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas. They set a "neutral" rating on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas. They set a "neutral" rating on the stock.
1/12
10:00 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating and a $38.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating and a $38.00 price target on the stock.
1/12
08:42 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $50.00 price target on the stock.
Medium
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $50.00 price target on the stock.
1/12
08:42 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Medium
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
1/12
08:42 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $42.00 price target on the stock.
Medium
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $42.00 price target on the stock.